ABSTRACT
In the German study of adjuvant radiotherapy (ARO 96-02/
AUO AP 09/95), which included only those patients with
undetectable PSA after RP, RT provided a 21% absolute
advantage in four-year freedom from biochemical progres-
sion (14). In summary, the medical evidence is compelling
in favor of the routine use of adjuvant postoperative RT in
appropriately selected patients (Table 1).
